{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:23:55Z","timestamp":1787801035505,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jns.2018.09.015","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T13:43:17Z","timestamp":1536846197000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["West Nile virus induces a post-infectious pro-inflammatory state that explains transformation of stable ocular myasthenia gravis to myasthenic crises"],"prefix":"10.1016","volume":"395","author":[{"given":"Maximiliano A.","family":"Hawkes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Hocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Arturo","family":"Leis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2018.09.015_bb0005","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1212\/WNL.0000000000003697","article-title":"Zika virus infection and myasthenia gravis: report of 2 cases","volume":"88","author":"Molko","year":"2017","journal-title":"Neurology United States"},{"key":"10.1016\/j.jns.2018.09.015_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.23869","article-title":"West nile virus infection and myasthenia gravis","volume":"49","author":"Leis","year":"2014","journal-title":"Muscle Nerve. United States"},{"key":"10.1016\/j.jns.2018.09.015_bb0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/08830738050200051501","article-title":"Postinfectious myasthenia gravis: report of two children","volume":"20","author":"Felice","year":"2005","journal-title":"J. Child Neurol. United States"},{"key":"10.1016\/j.jns.2018.09.015_bb0020","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneur.61.6.938","article-title":"Stiff-person syndrome following West Nile fever","volume":"61","author":"Hassin-Baer","year":"2004","journal-title":"Arch. Neurol. United States"},{"key":"10.1016\/j.jns.2018.09.015_bb0025","doi-asserted-by":"crossref","unstructured":"Sumner N, Jones L. Multifocal neuropathy associated with West Nile virus infection. Neurology. United States; 2008;71:1123.","DOI":"10.1212\/01.wnl.0000326964.26673.8e"},{"key":"10.1016\/j.jns.2018.09.015_bb0030","first-page":"1399","article-title":"West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario","volume":"168","author":"Pepperell","year":"2003","journal-title":"CMAJ. Canada"},{"key":"10.1016\/j.jns.2018.09.015_bb0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/WNL.55.1.144","article-title":"Guillain-Barre syndrome: an unusual presentation of West Nile virus infection","volume":"55","author":"Ahmed","year":"2000","journal-title":"Neurology. United States"},{"key":"10.1016\/j.jns.2018.09.015_bb0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun. England"},{"key":"10.1016\/j.jns.2018.09.015_bb0045","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1172\/JCI114282","article-title":"Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus","volume":"84","author":"Schwimmbeck","year":"1989","journal-title":"J. Clin. Invest. United States"},{"issue":"7","key":"10.1016\/j.jns.2018.09.015_bb0050","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.ophtha.2015.03.010","article-title":"Prognosis of ocular myasthenia gravis: retrospective multicenter analysis","volume":"122","author":"Nagia","year":"2015","journal-title":"Ophthalmology"},{"issue":"1\u20132","key":"10.1016\/j.jns.2018.09.015_bb0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jns.2008.05.023","article-title":"Prognosis of ocular myasthenia in Korea: a retrospective multicenter analysis of 202 patients","volume":"273","author":"Hong","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2018.09.015_bb0060","author":"Ocular Myasthenia Gravis"},{"issue":"2","key":"10.1016\/j.jns.2018.09.015_bb0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archneur.60.2.243","article-title":"Development of Generalized Disease at 2 years in patients with Ocular Myasthenia Gravis","volume":"60","author":"Kupersmith","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2018.09.015_bb0070","doi-asserted-by":"crossref","first-page":"196","DOI":"10.14740\/jocmr2413w","article-title":"Seropositivity for West Nile virus antibodies in patients affected by myasthenia gravis","volume":"8","author":"Greco","year":"2016","journal-title":"J. Clin. Med. Res. Canada"},{"key":"10.1016\/j.jns.2018.09.015_bb0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jtbi.2014.11.022","article-title":"Unresolved issues in theories of autoimmune disease using myocarditis as a framework","volume":"375","author":"Root-Bernstein","year":"2015","journal-title":"J. Theor. Biol."},{"issue":"12","key":"10.1016\/j.jns.2018.09.015_bb0080","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1086\/375231","article-title":"Unilateral brachial plexopathy associated with West Nile virus meningoencephalitis","volume":"36","author":"Almhanna","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jns.2018.09.015_bb0085","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4269\/ajtmh.2006.75.1232","article-title":"Myocarditis in West Nile Virus infection","volume":"75","author":"Pergam","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jns.2018.09.015_bb0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mus.21448","article-title":"Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection","volume":"41","author":"Petzold","year":"2010","journal-title":"Muscle Nerve. United States"},{"key":"10.1016\/j.jns.2018.09.015_bb0095","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/mus.23241","article-title":"Glial S100B is elevated in serum across the spectrum of West Nile virus infection","volume":"45","author":"Leis","year":"2012","journal-title":"Muscle Nerve. United States"},{"key":"10.1016\/j.jns.2018.09.015_bb0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jns.2015.09.003","article-title":"Does astroglial protein S100B contribute to West Nile neuro-invasive syndrome?","volume":"358","author":"Kuwar","year":"2015","journal-title":"J. Neurol. Sci. Netherlands"},{"key":"10.1016\/j.jns.2018.09.015_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virusres.2014.08.017","article-title":"High-mobility group box-1, promising serological biomarker for the distinction of human WNV disease severity","volume":"195","author":"Fraisier","year":"2015","journal-title":"Virus Res. Netherlands"},{"key":"10.1016\/j.jns.2018.09.015_bb0110","doi-asserted-by":"crossref","DOI":"10.1515\/revneuro-2015-0003","article-title":"Receptor for advanced glycation end-products in neurodegenerative","author":"Juranek","year":"2015","journal-title":"Dis. Rev. Neurosci."},{"key":"10.1016\/j.jns.2018.09.015_bb0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clim.2011.04.013","article-title":"Activation of the receptor for advanced glycation end products (RAGE) exacerbates experimental autoimmune myasthenia gravis symptoms","volume":"141","author":"Mu","year":"2011","journal-title":"Clin. Immunol. United States"},{"key":"10.1016\/j.jns.2018.09.015_bb0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbrc.2012.02.121","article-title":"The receptor for advanced glycation endproducts and its ligands in patients with myasthenia gravis","volume":"420","author":"Moser","year":"2012","journal-title":"Biochem. Biophys Res. Commun. United States"},{"key":"10.1016\/j.jns.2018.09.015_bb0125","article-title":"Interleukin-17A Promotes CD8+ T Cell Cytotoxicity to Facilitate West Nile Virus Clearance","volume":"91","author":"Acharya","year":"2017","journal-title":"J. Virol. United States"},{"key":"10.1016\/j.jns.2018.09.015_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2015.06.011","article-title":"Elevated plasma interleukin-17A in a subgroup of Myasthenia Gravis patients","volume":"78","author":"Xie","year":"2016","journal-title":"Cytokine. England"},{"key":"10.1016\/j.jns.2018.09.015_bb0135","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/eji.201445064","article-title":"IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis","volume":"45","author":"Schaffert","year":"2015","journal-title":"Eur J Immunol. Germany"},{"key":"10.1016\/j.jns.2018.09.015_bb0140","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/vim.2014.0035","article-title":"Evaluation of prolonged fatigue post-West Nile virus infection and association of fatigue with elevated antiviral and proinflammatory cytokines","volume":"27","author":"Garcia","year":"2014","journal-title":"Viral Immunol. United States"},{"key":"10.1016\/j.jns.2018.09.015_bb0145","series-title":"Poster Abstracts. 13th International Conference on Myasthenia Gravis and Related Disorders. NYAS. May 15\u201317","article-title":"West Nile virus induces a prolonged pro-inflammatory state that may promote myasthenia gravis","author":"Leis","year":"2017"},{"key":"10.1016\/j.jns.2018.09.015_bb0150","article-title":"A Cross-Sectional Study of Neurocognitive Outcomes in Post-West Nile Virus Infection","author":"Ronca","year":"2017","journal-title":"Am Soc Trop Med Hyg. ASTMH"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18303770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18303770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T00:28:25Z","timestamp":1541204905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18303770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":30,"alternative-id":["S0022510X18303770"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.09.015","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"West Nile virus induces a post-infectious pro-inflammatory state that explains transformation of stable ocular myasthenia gravis to myasthenic crises","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}